Evidence map›Paper›PMID 42432812›Full record

ArticleCardio-oncology (London, England)2026

Correction: Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement.

Susan Dent, Michelle B Nadler, Anne Blaes, Ahamed Iqbal, Hannah Naa Gogwe Ayettey, Jose Alvarez-Cardona, Alexandre Chan, Eng-Siew Koh, Raul Cordoba Mascunano, Mridula George and 10 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cardio-oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Susan DentWilmot Cancer Institute, University of Rochester, Rochester, NY, USA. susan_dent@urmc.rochester.edu.ORCID http://orcid.org/0000-0002-9183-9340
Michelle B NadlerPrincess Margaret Cancer Center, University Health Network and University of Toronto, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-4372-3204
Anne BlaesUniversity of Minnesota, Minneapolis, USA.ORCID http://orcid.org/0000-0002-5433-4810
Ahamed IqbalTeaching Hospital, Ministry of Health, Batticaloa, SriLanka, Sri Lanka.ORCID http://orcid.org/0000-0003-3506-6088
Hannah Naa Gogwe AyetteyNational Radiotherapy Oncology and Nuclear Medicine Centre, KorleBu Hospital, Accra, Ghana.
Jose Alvarez-CardonaLeon H Charney Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.ORCID http://orcid.org/0009-0001-0681-5708
Alexandre ChanDepartment of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, USA.ORCID http://orcid.org/0000-0003-4391-4219
Eng-Siew KohDepartment of Radiation Oncology, Liverpool Hospital, Liverpool South Wales, Australia, South West Sydney Clinical School, University of South Wales, Sydney, Australia.ORCID http://orcid.org/0000-0002-1664-2513
Raul Cordoba MascunanoFundacion Jimenez Diaz University Hospital, Madrid, Spain.
Mridula GeorgeRutgers Cancer Institute, New Brunswick, NJ, USA.ORCID http://orcid.org/0000-0003-2013-4017
Naa Adorkor AryeeteyNational Radiotherapy Oncology and Nuclear Medicine Centre, KorleBu Hospital, Accra, Ghana.
Erin J HowdenSchool of Health Sciences, University of New South Wales, Sydney, Australia.ORCID http://orcid.org/0000-0002-6657-4395
Sase KazuhiroClinical Pharmacy and Pharmacology an Regulatory Science, Juntendo University, Tokyo, Japan.
Nida LatifSection of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-2198-5190
Aya F OzakiDepartment of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, USA.ORCID http://orcid.org/0000-0003-0703-9322
Cherith J SempleInstitiute of Nursing and Health Research, Ulster University / Cancer Services, South Eastern Health and Social Care Trust, Belfast, UK.ORCID http://orcid.org/0000-0002-4560-7637
Sivatharshini RamalingamCardio-Oncology Center of Excellence, Royal Brompton Hospital, London, UK.ORCID http://orcid.org/0009-0009-2582-9548
Neil M IyengerWinship Cancer Institute, Emory University, Atlanta, Georgia, USA.ORCID http://orcid.org/0000-0002-9773-5235
Hope S RugoCity of Hope Comprehensive Cancer Center, Duarte, CA, USA.ORCID http://orcid.org/0000-0001-6710-4814
Bogda KoczwaraAustralian Research Centre for Cancer Survivorship, College of Medicine and Public Health, University of New South Wales, Flinders University, Sydney, Adelaide, Australia. b.koczwara@unsw.edu.au.ORCID http://orcid.org/0000-0002-1201-1642

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42432812
PMCPMC13352844

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.